A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid Use in Adults and Adolescents With Oral Corticosteroid Dependent Asthma (TROPOS)
Phase of Trial: Phase III
Latest Information Update: 14 Oct 2017
At a glance
- Drugs Tralokinumab (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms TROPOS
- Sponsors AstraZeneca
- 26 Sep 2017 Status changed from active, no longer recruiting to completed.
- 19 Jun 2017 Planned primary completion date changed from 7 Jun 2017 to 13 Sep 2017.
- 10 Jun 2017 Biomarkers information updated